What is the new painkiller that will replace opioids?: The Rise of Non-Addictive Analgesics
•
4 min read
In January 2025, the U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine), marking the first new oral, non-opioid painkiller with a novel mechanism of action in over two decades. This groundbreaking development answers the pressing question, *What is the new painkiller that will replace opioids?*, by offering a potent, non-addictive alternative for moderate to severe acute pain.
